Trials / Conditions / 2019 Novel Coronavirus Infection

2019 Novel Coronavirus Infection

10 registered clinical trials studyying 2019 Novel Coronavirus Infection.

Status	Trial	Sponsor	Phase
Unknown	Study and Analysis of Acute Pancreatitis Complicated With COVID-19 NCT05722678	Yuansong Sun	—
Withdrawn	Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendu NCT05085574	Leidos Life Sciences	Phase 2
Completed	Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Cli NCT05364268	AudibleHealth AI, Inc.	—
Unknown	Povidone Iodine Nasal Irrigation and Gargling to Reduce Viral Load in Asymptomatic Patients With COVID-19 NCT05375773	Ruijin Hospital	N/A
Terminated	Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVI NCT05077969	Leidos Life Sciences	Phase 2
Completed	LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) NCT05077332	Leidos Life Sciences	Phase 2
Terminated	Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 NCT04778059	US Biotest, Inc.	Phase 2
Unknown	Evaluating Clinical Parameters of COVID-19 in Pregnancy NCT04470583	Chelsea and Westminster NHS Foundation Trust	—
Unknown	PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs NCT04459351	Chelsea and Westminster NHS Foundation Trust	—
Unknown	Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff NCT04320238	Shanghai Jiao Tong University School of Medicine	Phase 3